Identification of novel NFKB1 and ICOS frameshift variants in patients with CVID

Clin Exp Immunol. 2023 Mar 8;211(1):68-77. doi: 10.1093/cei/uxac121.

Abstract

Common variable immunodeficiency (CVID) is a 'late-onset' primary immunodeficiency characterized by variable manifestations and genetic heterogeneity. A monogenic cause of CVID has been reported in 10% of patients. In this study, we identified two novel pathogenic variants implicated in monogenic CVID by whole exome sequencing (WES) analysis: a heterozygous nuclear factor κB subunit 1 (NFKB1) p.G686fs mutation and a homozygous inducible T-cell co-stimulator (ICOS) p.L96Sfs mutation. The predicted crystal models indicated premature truncation of the two mutated proteins. Both variants were demonstrated as loss-of-function mutations and were associated with overlapped manifestations of respiratory fungal infection and splenomegaly. We further performed a detailed assessment of immunologic phenotypes and impaired lymphocyte functions in patients. Moreover, we discovered an association between monoclonal T-large granular lymphocyte proliferation and ICOS-deficient CVID for the first time. These observations lead to a new perspective on the underlying genetic heterogeneity of CVID.

Keywords: CVID; ICOS; NFKB1; monogenic.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Common Variable Immunodeficiency* / genetics
  • Humans
  • Inducible T-Cell Co-Stimulator Protein / genetics
  • Mutation / genetics
  • NF-kappa B p50 Subunit / genetics
  • Phenotype

Substances

  • Inducible T-Cell Co-Stimulator Protein
  • NFKB1 protein, human
  • NF-kappa B p50 Subunit
  • ICOS protein, human